CO

Congyi Zhang1,2, Shizhuan Huang1, Kunhao Ding3

  • 1Department of Hepatic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.

Molecular pharmaceutics
|September 20, 2024
PubMed
概括

这项研究引入了新型纳米细胞,用于一氧化碳 (CO) 输送用于治疗肝癌 (HCC). 这些向的纳米细胞为HCC治疗提供了改善的CO释放和增强的抗瘤效果.